A 38-year-old woman with no significant past medical history presents with sudden-onset severe headache, confusion, and petechial rash. Blood pressure is 165/105 mmHg. Laboratory investigations show platelet count 45,000/μL, creatinine 2.8 mg/dL, hemoglobin 9.2 g/dL with schistocytes on blood smear, and normal PT/INR. A diagnosis of thrombotic thrombocytopenic purpura (TTP) is suspected. What is the most appropriate immediate next step in management?

Explanation

## Clinical Context This patient presents with the classic pentad of TTP: 1. **Microangiopathic hemolytic anemia** (schistocytes, low Hb) 2. **Thrombocytopenia** (45,000/μL) 3. **Neurological symptoms** (headache, confusion) 4. **Renal dysfunction** (Cr 2.8 mg/dL) 5. **Fever** (implied by clinical presentation) TTP is a medical emergency with mortality >90% if untreated. ## Pathophysiology of TTP ```mermaid flowchart TD A[ADAMTS13 deficiency]:::outcome --> B[Uncleaved vWF multimers accumulate]:::outcome B --> C[Platelet microthrombi formation]:::outcome C --> D[Mechanical hemolysis]:::action C --> E[End-organ ischemia]:::action D --> F[Schistocytes + hemolysis]:::outcome E --> G[Neurological/Renal dysfunction]:::outcome A --> H[Diagnosis: ADAMTS13 activity < 10%]:::outcome ``` ## Why Plasma Exchange Is the Correct Answer **Key Point:** Plasma exchange (PEX) is the ONLY life-saving treatment for TTP and must be started IMMEDIATELY on clinical suspicion — do NOT wait for ADAMTS13 confirmation. ### Mechanism of Plasma Exchange 1. **Removes** pathological vWF multimers and circulating immune complexes 2. **Replaces** deficient ADAMTS13 (in acquired TTP) 3. **Reduces** platelet consumption and microthrombi formation 4. **Restores** organ perfusion ### Evidence for Immediate Initiation - **Mortality without PEX:** >90% - **Mortality with PEX:** ~10–15% - **Delay in PEX:** Each day of delay increases mortality by ~5–10% - **ADAMTS13 testing:** Takes 24–48 hours; treatment must not wait **High-Yield:** "Suspect TTP, start PEX" — this is a time-critical diagnosis where empirical treatment is justified by the high mortality of untreated disease. ### Plasma Exchange Protocol - **Volume:** 1–1.5 plasma volumes per exchange - **Frequency:** Daily until platelet count >150,000/μL and LDH normalizes - **Duration:** Usually 5–14 days depending on response - **Replacement fluid:** Fresh frozen plasma (FFP) or solvent/detergent-treated plasma **Clinical Pearl:** Response to PEX is monitored by: - Platelet count recovery (most sensitive) - Declining LDH and reticulocyte count - Improvement in neurological symptoms - Stabilization of creatinine ## Differential Diagnosis: TTP vs. HUS vs. DIC | Feature | TTP | HUS | DIC | |---------|-----|-----|-----| | **Renal involvement** | Mild | Severe (AKI) | Variable | | **Neurological symptoms** | Prominent | Rare | Rare | | **Platelet count** | Severe ↓ | Moderate ↓ | Severe ↓ | | **PT/INR** | Normal | Normal | **Prolonged** | | **Fibrinogen** | Normal | Normal | **Low** | | **ADAMTS13** | **Deficient** | Normal | Normal | | **Treatment** | PEX | Supportive | Treat cause | **Warning:** This patient has NORMAL PT/INR, which rules out DIC. The severe thrombocytopenia with normal coagulation studies is pathognomonic for TTP.